NCT03538171 2021-07-09
Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer
Taizhou EOC Pharma Co., Ltd.
Phase 3 Unknown
Clinical Trials
7 trialsNCT00541086 2020-02-07
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
Gruppo Italiano Mammella (GIM)
Phase 3 Unknown
NCT03137368 2018-10-31
STEP
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Unknown
NCT02404051 2016-06-15
FEVEX
Consorzio Oncotech
Phase 3 Unknown
NCT00003418 2013-12-19
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00688194 2013-08-26
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00902954 2009-05-15
LEANEX
Fudan University
Phase 3 Unknown